CETN2 and POFUT1 immunolabeling was performed in tissues representing ESCC and precancerous lesions, which confirmed that the expression of CETN2 and POFUT1 increased with the severity of ESCC. Here, CETN2 is linked to esophageal squamous cell carcinoma.